![]()
|
|
||||||||
(Received for publication, November 7, 1995, and in revised form, February 21, 1996)
Hematology/Oncology Division, Department of Medicine, Beth Israel
Hospital, Harvard Medical School, Boston, Massachusetts 02215
PU.1 (spi-1), a member of the Ets
transcription factor family, is predominantly expressed in myeloid and
B cells, activates many B cell and myeloid genes, and is critical for
development of both of these lineages. Our previous studies (Chen, H. M., Ray-Gallet, D., Zhang, P., Hetherington, C. J., Gonzalez, D. A.,
Zhang, D.-E., Moreau-Gachelin, F., and Tenen, D. G. (1995)
Oncogene 11, 1549-1560) demonstrate that the
PU.1 promoter directs cell type-specific reporter gene
expression in myeloid cell lines, and that PU.1 activates its own
promoter in an autoregulatory loop. Here we show that the murine
PU.1 promoter is also specifically and highly functional in
B cell lines as well. Oct-1 and Oct-2 can bind specifically to a site
at base pair
Volume 271, Number 26,
Issue of June 28, 1996
pp. 15743-15752
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
55 in vitro, and this site is specifically
protected in B cells in vivo. We also demonstrate that two
other sites contribute to promoter activity in B cells; an Sp1 binding
site adjacent to the octamer site, and the PU.1 autoregulatory site.
Finally, we show that the B cell coactivator OBF-1/Bob1/OCA-B is only
expressed in B cells and not in myeloid cells, and that
OBF-1/Bob1/OCA-B can transactivate the PU.1 promoter in
HeLa and myeloid cells. This B cell restricted coactivator may be
responsible for the B cell specific expression of PU.1
mediated by the octamer site.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Wang, C. H. Lee, C. Qi, P. Tailor, J. Feng, S. Abbasi, T. Atsumi, and H. C. Morse III IRF8 regulates B-cell lineage specification, commitment, and differentiation Blood, November 15, 2008; 112(10): 4028 - 4038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mankai, A. Bordron, Y. Renaudineau, C. Martins-Carvalho, S. Takahashi, I. Ghedira, C. Berthou, and P. Youinou Purine-Rich Box-1-Mediated Reduced Expression of CD20 Alters Rituximab-Induced Lysis of Chronic Lymphocytic Leukemia B Cells Cancer Res., September 15, 2008; 68(18): 7512 - 7519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoogenkamp, H. Krysinska, R. Ingram, G. Huang, R. Barlow, D. Clarke, A. Ebralidze, P. Zhang, H. Tagoh, P. N. Cockerill, et al. The Pu.1 Locus Is Differentially Regulated at the Level of Chromatin Structure and Noncoding Transcription by Alternate Mechanisms at Distinct Developmental Stages of Hematopoiesis Mol. Cell. Biol., November 1, 2007; 27(21): 7425 - 7438. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. U. Mueller, T. Pabst, J. Fos, V. Petkovic, M. F. Fey, N. Asou, U. Buergi, and D. G. Tenen ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression Blood, April 15, 2006; 107(8): 3330 - 3338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ushmorov, F. Leithauser, O. Sakk, A. Weinhausel, S. W. Popov, P. Moller, and T. Wirth Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma Blood, March 15, 2006; 107(6): 2493 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Himes, D. P. Sester, T. Ravasi, S. L. Cronau, T. Sasmono, and D. A. Hume The JNK Are Important for Development and Survival of Macrophages J. Immunol., February 15, 2006; 176(4): 2219 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okuno, G. Huang, F. Rosenbauer, E. K. Evans, H. S. Radomska, H. Iwasaki, K. Akashi, F. Moreau-Gachelin, Y. Li, P. Zhang, et al. Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element Mol. Cell. Biol., April 1, 2005; 25(7): 2832 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hsu, D. Traver, J. L. Kutok, A. Hagen, T.-X. Liu, B. H. Paw, J. Rhodes, J. N. Berman, L. I. Zon, J. P. Kanki, et al. The pu.1 promoter drives myeloid gene expression in zebrafish Blood, September 1, 2004; 104(5): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salas and L. A. Eckhardt Critical Role for the Oct-2/OCA-B Partnership in Ig-Secreting Cells J. Immunol., December 15, 2003; 171(12): 6589 - 6598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Ward, D. O. McPhee, M. M. Condron, S. Varma, S. H. Cody, S. M. N. Onnebo, B. H. Paw, L. I. Zon, and G. J. Lieschke The zebrafish spi1 promoter drives myeloid-specific expression in stable transgenic fish Blood, November 1, 2003; 102(9): 3238 - 3240. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kummalue and A. D. Friedman Cross-talk between regulators of myeloid development: C/EBP{alpha} binds and activates the promoter of the PU.1 gene J. Leukoc. Biol., September 1, 2003; 74(3): 464 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jundt, K. Kley, I. Anagnostopoulos, K. Schulze Probsting, A. Greiner, S. Mathas, C. Scheidereit, T. Wirth, H. Stein, and B. Dorken Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease Blood, April 15, 2002; 99(8): 3060 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, Y. Okuno, P. Zhang, H. S. Radomska, H.-m. Chen, H. Iwasaki, K. Akashi, M. J. Klemsz, S. R. McKercher, R. A. Maki, et al. Regulation of the PU.1 gene by distal elements Blood, November 15, 2001; 98(10): 2958 - 2965. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Laribee and M. J. Klemsz Loss of PU.1 Expression Following Inhibition of Histone Deacetylases J. Immunol., November 1, 2001; 167(9): 5160 - 5166. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Andersen and M. G. Rosenfeld POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease Endocr. Rev., February 1, 2001; 22(1): 2 - 35. [Abstract] [Full Text] |
||||
![]() |
P. Zhang, X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding Blood, October 15, 2000; 96(8): 2641 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, Q. Su, and P. Tempst Differentiation-stimulated Activity Binds an ETS-like, Essential Regulatory Element in the Human Promyelocytic defensin-1 Promoter J. Biol. Chem., April 10, 1998; 273(15): 8727 - 8740. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Fisher and E. W. Scott Role of PU.1 in Hematopoiesis Stem Cells, January 1, 1998; 16(1): 25 - 37. [Abstract] [Full Text] |
||||
![]() |
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang Transcription Factors, Normal Myeloid Development, and Leukemia Blood, July 15, 1997; 90(2): 489 - 519. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |